Login / Signup

Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.

Kelly E DooleyBronwyn HendricksNikhil GupteGrace BarnesKim NarunskyColleen WhitelawTanya SmitElisa H IgnatiusAdine FriedmanSusan E DormanRodney Dawsonnull null
Published in: American journal of respiratory and critical care medicine (2022)
gov, ID: NCT02256696.
Keyphrases
  • mycobacterium tuberculosis
  • adverse drug
  • pulmonary tuberculosis
  • hiv aids
  • emergency department
  • randomized controlled trial
  • clinical trial
  • study protocol
  • hepatitis c virus
  • double blind